Platelet transfusions benefit patients with blood cancers

05/9/2013 | Medscape (free registration)

Prophylactic platelet transfusions lowered the risk of significant bleeding events in patients with blood cancers, according to a study in the New England Journal of Medicine. There was a 7% decrease in the proportion of bleeding events among patients who received platelets. "The results of our study support the need for the continued use of prophylaxis with platelet transfusion and show the benefit of such prophylaxis for reducing bleeding," researchers concluded.

View Full Article in:

Medscape (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice President, Science and Regulatory Affairs
American Beverage Association
Washington, DC
Senior Manager of Medical Management
Network Health
Medford, MA
MEDICAL SCIENCE LIAISON - 14000002RO
Abbott
Columbus, OH
Manager, Medical Management
Network Health
Medford, MA
Executive Medical Director
Aspirus Network Inc
Wausau, WI